April 17, 2025 01:15 PM EDT
Pharma
FDA+

GSK kicks off Blenrep re­launch plans with clear­ance from UK reg­u­la­tors

Nicole DeFeudis

Editor

The UK on Thurs­day au­tho­rized GSK’s Blenrep to treat cer­tain mul­ti­ple myelo­ma pa­tients in two dif­fer­ent reg­i­mens, mark­ing the drug’s first ap­proval world­wide since it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sanofi to pay $125M up­front for two im­munol­o­gy drugs from lit­tle-known biotech

US drugs re­ly heav­i­ly on in­gre­di­ents made over­seas, new re­port shows

Sarep­ta los­es CMO to RNA edit­ing up­start; An­oth­er wave of per­son­nel moves at Dyne

Ex­clu­sive: VelaV­i­go inks an­oth­er US biotech deal as Chi­na drug de­vel­op­ment scene booms

Biotech seed rounds sink to low­est lev­el in years as in­dus­try slump drags on

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times